TABLE 1.

Patient characteristics of 30 patients with MRSA infections for whom in vitro testing of a clinical isolate was performed

CharacteristicValue for groupa
VAN treatment successbVAN treatment failureP
Age in yr (mean ± SD [median])63 ± 15 (62)59 ± 17 (60)0.5
Sex0.7
    Male4 (57)9 (39)
    Female3 (43)14 (61)
Located in the ICU2 (29)10 (43)0.7
Log10 (CFU/ml) of killing (mean ± SD [median])6.26 ± 1.29 (6.27)4.88 ± 1.81 (5.10)0.07
  • a Data are no. (%) of patients.

  • b VAN, vancomycin.